1 Result(s)

Article

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study

This study investigated the potential clinical utility of circulating free DNA (cfDNA) as a source of BRAF mutation detection in patients enrolled into a phase II study of AZD6244, a specific MEK1/2 inhibitor, in...

R E Board, G Ellison, M C M Orr, K R Kemsley, G McWalter… in British Journal of Cancer (2009)